Average Co-Inventor Count = 1.16
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. University of Colorado (10 from 1,381 patents)
2. Other (4 from 832,843 patents)
3. Raytheon Company (2 from 8,187 patents)
4. Allergan, Inc. (1 from 2,285 patents)
5. University Technology Corporation (1 from 80 patents)
6. Schmidt, Richard A. (0 patent)
18 patents:
1. 9066943 - Use of botulinum toxin therapy for treatment of urological neurological conditions
2. 8840905 - Use of neurotoxin therapy for treatment of urologic and related disorders
3. 8445836 - System for maintaining an even temperature distribution across a laser detector
4. 8290726 - Photoconductive photodiode built-in test (BIT)
5. 8062643 - Use of neurotoxin therapy for treatment of urologic and related disorders
6. 8057807 - Use of botulinum toxin therapy for treatment of recalcitrant voiding dysfunction
7. 7981048 - Method and system for diagnosis of lower urinary tract dysregulation and related conditions
8. 7968104 - Use of neurotoxin therapy for treatment of urologic and related disorders
9. 7470431 - Use of neurotoxin therapy for treatment of urological-neurological disorders associated with prostate cancer
10. 7449192 - Use of neurotoxin therapy for treatment of urologic and related disorders related to neurogenic bladder dysfunction
11. 7431701 - Method and system for diagnosis of lower urinary tract dysregulation and related conditions
12. 7429387 - Use of botulinum toxin therapy for treatment of recalcitrant voiding dysfunction
13. 7153514 - Use of botulinum toxin therapy for prostatic hyperplasia and related disorders
14. 7001602 - Use of botulinum toxin therapy for urinary incontinence and related disorders
15. 6667041 - Use of neurotoxin therapy for treatment of urologic and related disorders